Enliven Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.3M | 77k | 17.59 |
| 2023-12-31 | $1.1M | 80k | 13.84 |
| 2023-09-30 | $1.1M | 81k | 13.66 |
| 2023-06-30 | $1.7M | 81k | 20.41 |
| 2023-03-31 | $335k | 15k | 21.90 |